Torrent Pharmaceuticals Fund Raise of ₹10,990 Cr

Torrent Pharmaceuticals Debt & Borrowing: ₹100 Cr

Torrent Pharmaceuticals partially redeemed Rs.100 Crore of its unlisted secured NCDs on 09-11-2026, leaving Rs.300 Crore outstanding. This is a debt servicing event, not compliance paperwork.

Value

₹100.0 Cr

Torrent Pharmaceuticals Legal & Regulatory

Torrent Pharma received a ₹3.12 Crore GST penalty order for pre-acquisition JB Chemicals periods. The company will appeal and expects no material impact.

Value

₹3.12 Cr

Torrent Pharmaceuticals Other Announcement

Torrent Pharmaceuticals disclosed that its RTA, KFin Technologies, is moving its corporate office effective December 1, 2026. Investors should update their records with the new address.

Torrent Pharmaceuticals Earnings Call Transcript: Key Takeaways

Revenue grew 51% following the JB Chemicals merger, but underlying business shows integration headwinds.

Call

Guides 10% growth

Torrent Pharmaceuticals Debt & Borrowing

Torrent Pharmaceuticals filed its security cover certificate as on 30-Sep-26 for listed NCDs, showing 141% market-value cover. Secured debt covered by the certificate stands at Rs 11,578.42 Crore.

Torrent Pharmaceuticals Q2 FY27 Results: Net Profit ₹534 Cr, Down 9.6% YoY

Torrent Pharmaceuticals Ltd reported revenue from operations of ₹4,979 Cr (+50.8% YoY) and net profit of ₹534 Cr (-9.6% YoY) for Q2 FY27.

Key figure

Net profit ₹534 Cr · -9.6% YoY

Om Metallogic Fund Raise

Om Metallogic Ltd intimated a board meeting on 14 November 2026 to approve rights issue issue price, entitlement ratio, record date and issue dates. The rights issue follows BSE in-principle approval.

Virinchi Fund Raise of ₹30 Cr

Virinchi's board approved a Rs 30 Crore preferential issue of 2 crore convertible warrants at Rs 15 each. Subject to EGM approval, allottees include promoter Viswanath Kompella.

Value

₹30.00 Cr

Execution

Warrant tenure not exceeding 18 months from allotment

IIFL Finance Fund Raise of ₹6,414 Cr

IIFL Finance's board approved a preferential issue of convertible preference shares and warrants worth Rs.6,414.20 Crore. Shareholder approval is needed at a 4 December EGM.

Value

₹6,414 Cr

Bajaj Finance Fund Raise of ₹5,800 Cr

Bajaj Finance's special committee approved issuing 5.74 crore warrants to promoter Bajaj Finserv at ₹1,010 each. The issue raises about ₹5,800 crore.

Value

₹5,800 Cr

Cholamandalam Investment & Finance Company Fund Raise of ₹5,000 Cr

Cholamandalam Investment sent shareholders a postal ballot notice seeking approval for a Rs 5,000 crore QIP. E-voting runs November 10 to December 9, 2026.

Value

₹5,000 Cr

Execution

Allotment to be completed within 365 days of shareholder approval

HB Leasing & Finance Co Fund Raise

HB Leasing's board discussed fund-raising options on November 9, 2026, including equity and preference shares. No quantum or pricing is decided; advisers will be consulted.